statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Latest Ratings for PRCT
 DateFirmActionFromTo Mar 2022B of A SecuritiesMaintainsBuy Mar 2022SVB LeerinkMaintainsOutperform Nov 2021SVB LeerinkMaintainsOutperform
 View More Analyst Ratings for...

Unveiling 4 Analyst Insights On PROCEPT BioRobotics

PROCEPT BioRobotics Co. (NASDAQ:PRCT - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six analysts that are presently covering the company, MarketBeat reports. Six...

Analysts Set PROCEPT BioRobotics Co. (NASDAQ:PRCT) Target Price at $45.60

SAN JOSE, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative...

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

SAN JOSE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the Company ) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing...

PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024

PROCEPT BioRobotics Co. (NASDAQ:PRCT - Free Report) - Stock analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of PROCEPT BioRobotics in a research report...

Leerink Partnrs Weighs in on PROCEPT BioRobotics Co.'s Q2 2025 Earnings (NASDAQ:PRCT)

Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $1.40 per share a year ago. These...

Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates

PROCEPT BioRobotics Corp (PRCT) President and CEO Reza Zadno Sells Company Shares

Investors in PROCEPT BioRobotics Corp (PRCT) saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...

First Week of May 17th Options Trading For PROCEPT BioRobotics (PRCT)

Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT  Get Free Report) have been given a consensus recommendation of Buy by the six research firms that are covering the firm...

PROCEPT BioRobotics Co. (NASDAQ:PRCT) Given Consensus Rating of "Buy" by Analysts

PROCEPT BioRobotics (NASDAQ:PRCT  Get Free Report) and DexCom (NASDAQ:DXCM  Get Free Report) are both medical companies, but which is the superior business? We will contrast the two...

PROCEPT BioRobotics (NASDAQ:PRCT) versus DexCom (NASDAQ:DXCM) Financial Contrast

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Watchers	416
52-Wk Low	$24.83
52-Wk High	$65.00

Volume	411,490.00
52-Wk High	$65.00
52-Wk Low	$24.83

PRCT Procept BioRobotics Corp

About

Feed

News

Sentiment

Earnings

Fundamentals